Medical Devices Series A Investors & VC Firms
1128 firms in this list, with a median first check of $500K. 245 of them lead rounds. Generated from verified public data and updated continuously.
Pathway to Cures
New YorkSeed–Series A
19 people
WELL Ventures
VancouverSeed–Series A
16 people
Boomerang Ventures
IndianapolisSeed–Growth$250K – $1.5M
9 people
LBBW Venture Capital GmbH
StuttgartSeed–Series A$540K – $3.2M
9 people
Martlet Capital
CambridgePre-Seed–Series A$317.5K
6 people
China Growth Capital
BeijingSeed–Series A
8 people
Trans-Pacific Technology Fund
TaipeiSeed–Growth
17 people
Foreground Capital
BostonSeed–Series B
9 people
Breakthrough Victoria
MelbournePre-Seed–Growth
7 people
Roche Venture Fund
BaselSeed–Growth$648K – $3.2M
7 people
4BIO Capital
LondonSeed–Series A
14 people
Global Blockchain Ventures
OrlandoSeries A
12 people
MedMountain Ventures
Salt Lake CityPre-Seed–Series A$500K – $5M
9 people
Pallasite Ventures
VancouverSeed–Series A$100K – $1.5M
1 person
ANDHealth ACTIVATE
MelbournePre-Seed–Series A
19 people
Champel Capital
JerusalemSeed–Late Stage
14 people
SATUS Venture Sp. z o.o.
KrakówPre-Seed–Series A$108K – $6.5M
7 people
Sanara Capital
Ra'ananaSeed–Series B
15 people
AMR Action Fund
BostonSeed–Growth
13 people
DigiTx Partners LLC
San FranciscoSeed–Series A$2M – $5M
8 people
JLS
New YorkSeed–Series B
14 people
Kinled Holding
Hong KongSeed–Series A
1 person
Aphelion Capital
Seed–Series B
10 people
Equitage Ventures, L.L.C.
DenverSeed–Series A$250K – $2.5M
10 people
Related lists
Series A Investors & VC Firms (7326)Series A Investors & VC Firms in North America (4220)Series A Investors & VC Firms in United States (3839)AI & Machine Learning Series A Investors & VC Firms (2601)SaaS Series A Investors & VC Firms (2591)Series A Investors & VC Firms in Europe (2384)Fintech Series A Investors & VC Firms (2350)Healthtech Series A Investors & VC Firms (2310)Enterprise Software Series A Investors & VC Firms (2265)Series A Investors & VC Firms in Global (2211)
Data sourced from public filings and firms' own websites — see our methodology.
































































































